Calcineurin Inhibitors With Reduced-Dose Steroids as First-Line Therapy for Focal Segmental Glomerulosclerosis

INTRODUCTION: High-dose corticosteroids remain the first-line therapy for focal and segmental glomerulosclerosis (FSGS), whereas calcineurin inhibitors (CNIs) are reserved for those patients resistant to corticosteroid therapy. METHODS: This is a retrospective cohort analysis in patients with primar...

Descripción completa

Detalles Bibliográficos
Autores principales: Chávez-Mendoza, Carlos Adrián, Niño-Cruz, José Antonio, Correa-Rotter, Ricardo, Uribe-Uribe, Norma Ofelia, Mejía-Vilet, Juan Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308907/
https://www.ncbi.nlm.nih.gov/pubmed/30596167
http://dx.doi.org/10.1016/j.ekir.2018.08.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308907/
https://www.ncbi.nlm.nih.gov/pubmed/30596167
http://dx.doi.org/10.1016/j.ekir.2018.08.010

Ejemplares similares